Skip to content
Disclosery

13F-HR filed by RHO CAPITAL PARTNERS INC

RHO CAPITAL PARTNERS INC filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-13, with 3 holding rows worth $57,538,000.

Accession
0001420506-18-000141
Filer
CIK 1020455
Filed
2018-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2017

A holdings report, 3 entries on the cover page, a total value of $57,538,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $57,538,000 with VALUE read as thousands by filing date, 13F file number 028-05883. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CARA THERAPEUTICS INC140755109COM3,568,057$43,673,000thousands by filing date
Mersana Therapeutics Inc59045L106Common Stock818,033$13,440,000thousands by filing date
SENSEONICS HLDGS INC81727U105COM159,601$425,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-18-000141this filing2018-02-13acceptance time not in the bulk data set